Signorelli SS , Anzaldi M., Fiore V., et al. Study on unrecognized peripheral arterial disease (PAD) by ankle/brachial index and arterial co-morbidity in Catania (Sicily, Italy). Angiology. IN PRESS.
2.
El-Menyar A. , Amin H., Rashdan I., et al. Ankle-brachial index and extent of atherosclerosis in patients from the Middle East (the AGATHA-ME study): a cross-sectional multicentre study. Angiology. 2009;60(3):329-334.
3.
Daskalopoulou SS, Pathmarajah M., Kakkos SK, et al. Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J. 2008; 72(3):441-448.
4.
Paraskevas KI , Mikhailidis DP, Liapis CDInternal carotid artery occlusion: association with atherosclerotic disease in other arterial beds and vascular risk factors . Angiology. 2007;58(3):329-335.
5.
Poredos P., Jug B.The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology. 2007 ;58(3):309-315.
6.
Ogren M., Hedblad B., Isacsson SO, Janzon L., Jungquist G., Lindell SENon-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis. Lancet. 1993; 342(8880):1138-1141.
7.
Marek J., Mills JL, Harvich J., Cui H., Fujitani RMUtility of routine carotid duplex screening in patients who have claudication . J Vasc Surg. 1996;24(4):572-577.
8.
Allan PL, Mowbray PI, Lee AJ, Fowkes FGRelationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke . 1997;28(2):348-353.
9.
Mostaza JM, Gonzalez-Juanatey JR , Castillo J., Lahoz C., Fernandez-Villaverde JM, Maestro-Saavedra FJPrevalence of carotid stenosis and silent myocardial ischemia in asymptomatic subjects with a low ankle-brachial index. J Vasc Surg.2009; 49(1):104-108.
10.
Flu WJ, van Kuijk JP, Voute MT, et al. Asymptomatic low anklebrachial index in vascular surgery patients: a predictor of perioperative myocardial damage. Eur J Vasc Endovasc Surg.2010; 39(1):62-69.
11.
Bo M., Corsinovi L., Brescianini A., et al. High-sensitivity C-reactive protein is not independently associated with peripheral subclinical atherosclerosis. Angiology.2009;60(1): 12-20.
12.
Paraskevas KI, Bessias N., Papas TT, Andrikopoulos V., Mikhailidis DPIs high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?Angiology. 2009; 60(1):8-11.
13.
Alnaeb ME, Boutin A., Crabtree VP, Mikhailidis DP, Seifalian AM, Hamilton G.Assessment of lower extremity peripheral arterial disease using a novel automated optical device. Vasc Endovasc Surg. 2007;41(6):522-527.
14.
Paraskevas KI, Papas TT, Pavlidis P., Bessias N., Andrikopoulos V.The importance of conservative measures in peripheral arterial disease: an update. Angiology. 2008;59(5):529-533.
15.
Mangiafico RA, Fiore CECurrent management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies . Curr Vasc Pharmacol.2009; 7(3):394-413.
Barrows RJ, Krumsdorf U., Zankl A., Katus H., Tiefenbacher CPSignificance of close surveillance of patients with peripheral arterial disease . Angiology.2009;60(4):462-467.
18.
Mukherjee D. , Eagle K.The importance of early diagnosis and treatment in peripheral arterial disease: insights from the PARTNERS and REACH registries . Curr Vasc Pharmacol. In Press.
19.
Maksimovic M., Vlajinac H., Radak D., Marinkovic J., Jorga J.Relationship between peripheral arterial disease and metabolic syndrome. Angiology.2009;60(5):546-553.
20.
Daskalopoulou SS, Daskalopoulos ME, Mikhailidis DP, Liapis CDLipid management and peripheral arterial disease . Curr Drug Targets. 2007;8(4):561-570.
21.
Alnaeb ME, Alobaid N., Seifalian AM, Mikhailidis DP, Hamilton G.Statins and peripheral arterial disease: potential mechanisms and clinical benefits. Ann Vasc Surg.2006;20(5): 696-705.
22.
Paraskevas KI , Giannoukas AD, Mikhailidis DPRenal function impairment in peripheral arterial disease: an important parameter that should not be neglected. Ann Vasc Surg.2009;23(5):690-699.
23.
Paraskevas KI , Liapis CD, Hamilton G., Mikhailidis DPCan statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg. 2006;32(6):286-293.
24.
Paraskevas KI , Athyros VG, Briana DD, Kakafika AI, Karagiannis A., Mikhailidis DPStatins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007;8(8):942-951.
25.
Dharmasaroja PARisk factors of carotid stenosis in Thai ischemic stroke/TIA patients. Angiology. . IN PRESS.
26.
Youssef F., Gupta P., Mikhailidis DP, Hamilton G.Risk modification in patients with peripheral arterial disease: a retrospective survey. Angiology. 2005;56(3):279-287.
27.
Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004; 109(6):733-739.